Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson’s disease-Reference-Cited by-同舟云学术

Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson’s disease

Published:2020-06 Issue: Volume:729 Page:134932
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Koski Sini K.,Leino Sakari,Panula Pertti,Rannanpää Saara,Salminen Outi^ORCID

Funder

Academy of Finland

Finnish Parkinson Foundation

Publisher

Elsevier BV

Subject

General Neuroscience

Reference31 articles.

1. Parkinson’s disease: mechanisms and models;Dauer;Neuron,2003

2. Motor complications in Parkinson’s disease: striatal molecular and electrophysiological mechanisms of dyskinesias;Picconi;Mov. Disord.,2018

3. Interaction of brain histaminergic and dopaminergic systems;Nuutinen,2016

4. An altered histaminergic innervation of the substantia nigra in Parkinson’s disease;Anichtchik;Exp. Neurol.,2000

5. Decrease in blood histamine in drug-treated Parkinsonian patients;Coelho;Mol. Chem. Neuropathol.,1991

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bis(benzimidazol‐2‐yl)amine‐Based DPP‐4 Inhibitors Potentially Suitable for Combating Diabetes and Associated Nervous System Alterations;Chemistry & Biodiversity;2024-09-09

2. Drug repurposing: Clemastine fumarate and neurodegeneration;Biomedicine & Pharmacotherapy;2023-01

3. Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease;Advances in Neurobiology;2023

4. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics;Neurochemistry International;2022-06

5. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy;Progress in Brain Research;2021